Search Result "anti-tumour modality"
Design of Anti-Fasn Molecules as a New Anti-Tumour Modality
Ebook: Frontiers in Drug Design and Discovery
Volume: 5 Year: 2010
Author(s): J. Relat,T. Puig
Doi: 10.2174/978160805203511005010168
The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 8 Issue: 1 Year: 2013 Page: 13-23
Author(s): Elizabeth Harford-Wright, Kate M. Lewis, Robert Vink
Altered Glycosylation of Proteins in Cancer: What Is the Potential for New Anti-Tumour Strategies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 2-21
Author(s): S. A. Brooks, T. M. Carter, L. Royle, D. J. Harvey, S. A. Fry, C. Kinch, R. A. Dwek, P. M. Rudd
Treatment Modalities for Hepatocellular Carcinoma
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 2 Year: 2005 Page: 131-138
Author(s): Huynh Hung
Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3 Issue: 5 Year: 2003 Page: 375-382
Author(s): Johannes Classen, Wilfried Budach
Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 5 Year: 2007 Page: 519-535
Author(s): Christoph Oehler, Daniel J. Dickinson, Angela Broggini-Tenzer, Barbara Hofstetter, Andreas Hollenstein, Oliver Riesterer, Van Vuong, Martin Pruschy
Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3 Issue: 2 Year: 2008 Page: 105-113
Author(s): Marko Lens, Pier F. Ferrucci, Alessandro Testori
Cytokines Play a Key Role in Communication between Mesenchymal Stem Cells and Brain Cancer Cells
Journal: Protein & Peptide Letters
Volume: 22 Issue: 4 Year: 2015 Page: 322-331
Author(s): Helena Motaln,Tamara Lah Turnsek
Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 3288-3299
Author(s): Harun M. Said, Claudiu T. Supuran, Carsten Hageman, Adrian Staab, Buelent Polat, Astrid Katzer, Andrea Scozzafava, Jelena Anacker, Michael Flentje, Dirk Vordermark
Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2983-2998
Author(s): Eyal Mishani, Galith Abourbeh, Martin Eiblmaier, Carolyn J. Anderson